Long circulating microparticulate drug carriers

To exert its activity a drug must reach its pharmacological site(s) of action(s) within the body. One of the current approaches to achieve site specific delivery utilises the use of a carrier. This review focuses on the physicochemical and biological properties of polymeric particulate carriers in the nanometre size range surface modified by poly(ethylene oxide) (PEO). Such systems are able to bypass the normal physiological defence processes occurring after the intravenous injection of particulates and, depending on the particle size and PEO layer properties, remain for a prolonged period of time in the systemic circulation, or have a degree of selectivity for sites of deposition within the body.

[1]  D. Sentenac,et al.  Structure and interactions in black films , 1996 .

[2]  Lisbeth Illum,et al.  Polymers in Controlled Drug Delivery , 1988 .

[3]  R. Bodmeier,et al.  Indomethacin polymeric nanosuspensions prepared by microfujidization , 1990 .

[4]  R. Müller,et al.  In vitro characterization of poly(methyl-methaerylate) nanoparticles and correlation to their in vivo fate , 1992 .

[5]  K. Caldwell,et al.  Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats. , 1993, Biomaterials.

[6]  G. J. Fleer,et al.  Polymers at Interfaces , 1993 .

[7]  R. Müller,et al.  Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. , 1987, Biomaterials.

[8]  M. Davies,et al.  The preparation of sub-200 nm biodegradable colloidal particles from poly(β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants , 1994 .

[9]  J. Andrade,et al.  Blood-materials interactions: the minimum interfacial free energy and the optimum polar/apolar ratio hypotheses. , 1982, Journal of biomedical materials research.

[10]  H M Patel,et al.  Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.

[11]  Finlay MacRitchie,et al.  Protein adsorption at solid-liquid interfaces: Reversibility and conformation aspects , 1986 .

[12]  M. Davies,et al.  The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process , 1989 .

[13]  P. Stenius,et al.  The effect of surface polarity on the adsorption of nonionic surfactants. II Adsorption on poly(methyl methacrylate) latex , 1984 .

[14]  E. Tomlinson,et al.  Adsorption of fibrinogen on to polystyrene latex coated with the non-ionic surfactant, poloxamer 338. , 1988, Biomaterials.

[15]  T. Tadros.  The Effect of Polymers on Dispersion Properties , 1982 .

[16]  W. Norde,et al.  The adsorption of HPA and Bovine Pancreas Ribonuclease at Negatively Charged Polystyrene Latices. II. Hydrogen-Ion Titrations , 1978 .

[17]  Y. Missirlis,et al.  Modern aspects of protein adsorption on biomaterials , 1991 .

[18]  A. Vrij,et al.  Preparation of sterically stabilized silica dispersions in nonaqueous media , 1981 .

[19]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[20]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[21]  E. Brown,et al.  Complement activation. , 1981, Immunology today.

[22]  R. Kjellander,et al.  Water structure and changes in thermal stability of the system poly(ethylene oxide)–water , 1981 .

[23]  R. Zollars,et al.  Effects of ionizable groups on the adsorption of surfactants onto latex particle surfaces , 1987 .

[24]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide: II. Effect of protein size , 1991 .

[25]  K. Caldwell,et al.  Surface Properties of Pluronic-Coated Polymeric Colloids , 1994 .

[26]  R. Müller,et al.  The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.

[27]  P. Stenius,et al.  The effect of surface polarity on the adsorption of nonionic surfactants. I: Thermodynamic considerations , 1984 .

[28]  S. Davis,et al.  Targeting of colloidal particles to the bone marrow. , 1987, Life sciences.

[29]  Yoshiaki,et al.  Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .

[30]  M. Kawaguchi,et al.  Polymer adsorption at solid-liquid interfaces , 1992 .

[31]  A. Hoffman,et al.  Protein Adsorption to and Elution from Polyether Surfaces , 1992 .

[32]  A. Gabizon,et al.  The role of surface charge and hydrophilic groups on liposome clearance in vivo. , 1992, Biochimica et biophysica acta.

[33]  T. Tadros,et al.  Influence of temperature and electrolytes on the adsorption of poly(ethylene oxide)-poly(propylene oxide) block copolymer on polystyrene latex and on the stability of the polymer-coated particles , 1980 .

[34]  T. Gray,et al.  Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes , 1994, FEBS letters.

[35]  S. Davis,et al.  The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.

[36]  Kinam Park,et al.  Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. , 1992, Biomaterials.

[37]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[38]  T. Cosgrove.  Volume-fraction profiles of adsorbed polymers , 1990 .

[39]  J. Herron,et al.  Molecular Simulation of Protein-PEG Interaction , 1992 .

[40]  S. Davis,et al.  Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits , 1986 .

[41]  B. Siffert,et al.  Adsorbed polymer layer thickness determination at the solid—liquid interface by different techniques , 1992 .

[42]  Martyn C. Davies,et al.  In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers , 1997 .

[43]  P. Stenius,et al.  Adsorption of nonylphenol—poly(propylene oxide)—poly(ethylene oxide) nonionic surfactants on polystyrene latex , 1984 .

[44]  T M Allen,et al.  Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.

[45]  D. H. Napper,et al.  Studies of the steric stabilization of colloidal particles , 1971 .

[46]  M C Davies,et al.  Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. , 1991, Biomaterials.

[47]  V. Kolb-Bachofen,et al.  Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.

[48]  B. Vincent,et al.  Polymer adsorption and dispersion stability , 1984 .

[49]  R. Bodmeier,et al.  Spontaneous formation of drug-containing acrylic nanoparticles. , 1991, Journal of microencapsulation.

[50]  M. Malmsten,et al.  Adsorption of PEO-PPO-PEO block copolymers at silica , 1992 .

[51]  P. A. Martic,et al.  Protein adsorption on pluronic copolymer-coated polystyrene particles , 1989 .

[52]  T. Tadros.  Polymers at interfaces , 1995 .

[53]  A. Gast,et al.  Block copolymers at interfaces. 2. Surface adsorption , 1988 .

[54]  M. Davies,et al.  The colloidal properties of surfactant-free biodegradable nanospheres from poly(β-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide) , 1995 .

[55]  R. Richards,et al.  Polymer surfaces and interfaces , 1987 .

[56]  S. Davis,et al.  Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. , 1994, Critical reviews in therapeutic drug carrier systems.

[57]  G. J. Fleer,et al.  Block copolymer adsorption and stabilization of colloids , 1990 .

[58]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[59]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[60]  F. Macritchie.  The adsorption of proteins at the solid/liquid interface , 1972 .

[61]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Y Ikada,et al.  Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. , 1988, Biomaterials.

[63]  C. J. Oss,et al.  Phagocytosis as a Surface Phenomenon , 1978 .

[64]  Y. Ikada,et al.  Phagocytosis of polymer microspheres by macrophages , 1990 .

[65]  L. Illum,et al.  Influence of block copolymers on the adsorption of plasma proteins to microspheres. , 1993, Biomaterials.

[66]  K. Caldwell,et al.  Sedimentation field flow fractionation in the determination of surface concentration of adsorbed materials , 1991 .

[67]  J. Benoit,et al.  Microencapsulation of peptide: a study of the phase separation of poly(d,l-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil , 1989 .

[68]  G. Schmid,et al.  Introduction to Modern Colloid Science , 1995 .

[69]  L. Illum,et al.  Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. , 1992, Biomaterials.

[70]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[71]  S. Davis,et al.  The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow , 1992, FEBS letters.

[72]  S. Davis.  Microspheres and drug therapy : pharmaceutical, immunological, and medical aspects , 1984 .

[73]  T. Epperly,et al.  A new long-acting injectable microcapsule system for the administration of progesterone. , 1979, Fertility and sterility.

[74]  P. Luckham,et al.  Rheology of polyethylene oxide—polypropylene oxide block copolymer stabilized latices and emulsions , 1994 .

[75]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide , 1991 .

[76]  D. Lewis,et al.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. , 1984, Journal of pharmaceutical sciences.

[77]  F. Davis,et al.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.

[78]  A S Hoffman,et al.  Protein adsorption to poly(ethylene oxide) surfaces. , 1991, Journal of biomedical materials research.

[79]  S. Davis,et al.  An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.

[80]  J. H. Lee,et al.  Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. , 1989, Journal of biomedical materials research.

[81]  E. Killmann,et al.  Dynamic light scattering of polystyrene latex and silica with adsorbed poly(ethylene oxide) layers — influence of ionic strength and coverage , 1994 .

[82]  A. Coombes,et al.  The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery , 1993 .

[83]  Min Y. Lin,et al.  Structure and interactions in tethered-chain systems , 1994 .

[84]  P. A. Martic,et al.  Protein Adsorption and Conformational Change on Small Polymer Particles , 1990 .

[85]  Jean-Pierre Benoit,et al.  Preparation of Poly(D,L-Lactide/Glycolide) Nanoparticles of Controlled Particle Size Distribution: Application of Experimental Designs , 1992 .

[86]  A. Hoffman,et al.  Water Structure of PEG Solutions by Differential Scanning Calorimetry Measurements , 1992 .

[87]  P. Gennes,et al.  Scaling theory of polymer adsorption : proximal exponent , 1983 .

[88]  G. Poste,et al.  Targeting of Drugs With Synthetic Systems , 1985, NATO ASI Series.

[89]  G. J. Fleer,et al.  Statistical thermodynamics of block copolymer adsorption. Part 2.—Effect of chain composition on the adsorbed amount and layer thickness , 1990 .

[90]  G. J. Fleer,et al.  Diblock copolymer adsorption on small particles. , 1994 .

[91]  C. Gölander,et al.  Characterization of hydrophobicity gradients prepared by means of radio frequency plasma discharge. , 1990, Biomaterials.

[92]  S. Nagaoka,et al.  Interaction Between Blood Components and Hydrogels With Poly(Oxyethylene) Chains , 1984 .

[93]  S. Moghimi,et al.  Serum factors that regulate phagocytosis of liposomes by Kupffer cells. , 1993, Biochemical Society transactions.

[94]  S. Davis,et al.  Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. , 1983, Journal of pharmaceutical sciences.

[95]  M. Poznansky,et al.  Biological approaches to the controlled delivery of drugs: a critical review. , 1984, Pharmacological reviews.

[96]  R. Müller.  Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization, and In Vivo Distribution , 1991 .

[97]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[98]  H. Fessi,et al.  In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules. , 1990, Journal of pharmaceutical sciences.

[99]  J. Baker,et al.  Investigation of the adsorption configuration of polyethylene oxide and its copolymers with polypropylene oxide on model polystyrene latex dispersions , 1988 .

[100]  R. Müller,et al.  Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908 , 1993 .

[101]  S. Moghimi,et al.  Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol‐rich liposomes , 1988, FEBS letters.

[102]  L. Leibler.  Block copolymers at interfaces , 1991 .

[103]  P. Rohdewald,et al.  Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs , 1985 .

[104]  P. B. Deasy,et al.  Microencapsulation and related drug processes , 1984 .

[105]  C. Morin,et al.  Biodegradable nanocapsules containing a lipophilic immunomodulator: drug retention and tolerance towards macrophages in vitro. , 1993, Journal of drug targeting.

[106]  Hsin-Jiant Liu,et al.  Structural analysis and degradation behavior in polyethylene glycol/poly(L‐lactide) copolymers , 1994 .

[107]  O. Evers.  Statistical thermodynamics of block copolymer adsorption. , 1990 .

[108]  P. Artursson,et al.  Preparation of sterically stabilized nanoparticles by desolvation from graft copolymers , 1990 .

[109]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[110]  D. Rawlins,et al.  Adsorption characteristics of certain polyoxyethylene-polyoxypropylene block co-polymers on polystyrene latex , 1979 .

[111]  S. Davis,et al.  The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages , 1986 .

[112]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[113]  D. Hochstrasser,et al.  Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.

[114]  Feng Liu,et al.  Amphipathic polyethylene glycol stabilized emulsions (o/w): Physical characterization and in vivo distribution , 1995 .

[115]  J. Joanny,et al.  Adsorption of block copolymers in selective solvents , 1988 .

[116]  J. M. Harris,et al.  Poly(Ethylene Glycol) Chemistry Biotechnical and Biomedical Applications , 1992 .

[117]  Jacob N. Israelachvili,et al.  Intermolecular and surface forces : with applications to colloidal and biological systems , 1985 .

[118]  Stuart L. Cooper,et al.  Protein adsorption on polymeric biomaterials I. Adsorption isotherms , 1988 .

[119]  J. Andrade,et al.  Properties of Immobilized PEG Films and the Interaction with Proteins , 1992 .

[120]  Moghimi Sm,et al.  Serum factors that regulate phagocytosis of liposomes by Kupffer cells , 1993 .

[121]  G. Gregoriadis,et al.  Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. , 1974, European journal of biochemistry.

[122]  G. D. Parfitt.  Polymer adsorption and dispersion stability , 1985 .

[123]  W. Norde,et al.  The behavior of some model proteins at solid-liquid interfaces. 2. Sequential and competitive adsorption. , 1990 .

[124]  A. Hoffman,et al.  Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection. , 1994, Journal of biomaterials science. Polymer edition.

[125]  J. Baker,et al.  Influence of particle curvature on polymer adsorption layer thickness , 1989 .

[126]  Nandini V. Katre,et al.  The conjugation of proteins with polyethylene glycol and other polymers: Altering properties of proteins to enhance their therapeutic potential , 1993 .